Skip to content

RNTX RNTX Deferred Tax Assets

Deferred Tax Assets at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$161M-96.0%
Gilead Sciences logo
Gilead SciencesGILD
$179M-74.8%
AbbVie logo
AbbVieABBV
$137M-94.7%
CTO
Citius Oncology, Inc.CTOR
$2.82M+24.9%
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
$7.72M+32.7%
LQD
Liquidia CorporationLQDA
$873K

Other financials

Income statement

See full
Revenue-
Operating income-$5.2M+6.8%
Net income-$5.8M-6.1%
EPS (diluted)-$0.19+24.0%

Balance sheet

See full
Cash & equivalents$4.4M-40.2%
Total debt$48.0K0.0%
Total equity$6.9M-63.0%
Total assets$26.3M-54.4%

Cash flow

See full
Operating cash flow-$3.4M+44.6%
CapEx-
Free cash flow-$6.3M

Valuation

See full
Market cap$88.96M+164%

Returns & leverage

See full
Return on equity-123.3%+86.1pp
Debt / equity0.0×
Current ratio0.4×-1.0×

Where this comes from

Reported directly by RNTX in its filing.

Tagged under the XBRL concept us-gaap:DeferredIncomeTaxLiabilitiesNet.

The official record: RNTX’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about RNTX's deferred tax assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is RNTX's deferred tax assets?
RNTX (RNTX) reported deferred tax assets of $1.06M in Q1 2026.
How has RNTX's deferred tax assets changed year-over-year?
RNTX's deferred tax assets decreased by 40.2% year-over-year, from $1.77M to $1.06M.
What is the long-term trend for RNTX's deferred tax assets?
Over 2 years (2023 to 2025), RNTX's deferred tax assets has grown at a -43.5% compound annual growth rate (CAGR), from $3.33M to $1.06M.
What does deferred tax assets mean?
Future tax benefits from temporary differences, net operating loss carryforwards, and tax credit carryforwards that will reduce future tax payments.